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AbsTrACT
background: Radial access is the object of increasing interest 
for interventional cardiologists, providing several advantages, 
including a reduction of bleeding and major adverse cardio-
vascular event (MACE) rates. However, even though elderly 
patients have a greater risk of access site bleedings, the use 
of the radial approach is controversial, due to the greater 
anatomical complexity of these patients. Methods: Retro-
spective study including patients undergoing percutaneous 
coronary intervention (PCIs) using the radial access divided 
into an elderly (> 65 years) and a non-elderly (< 65 years) 
group. Clinical, angiographic and procedural characteristics 
as well as early and late follow-up outcomes were analyzed. 
results: The elderly group included 131 patients (145 PCIs) 
and the non-elderly group, 149 patients (176 PCIs). The elderly 
group presented lower body mass index and fewer smokers 
and higher rates of chronic renal failure, peripheral arterial 
disease, stable coronary artery disease, multivessel disease 
and calcified lesions. There was no difference in the rate of 
access-site crossover (4.8% vs. 3.4%), fluoroscopy time (15.3 ± 
10.3 minutes vs. 16.1 ± 10.3 minutes), procedure time (40.6 ± 
26.4 minutes vs 46.4 ± 53.6 minutes), angiographic (96.3% vs 
97.5%) and clinical (94.5% vs 95.4%) success, MACE (3.4% vs 
3.4%) and bleedings (0.21% vs 0.6%) during hospitalization. In 
the late follow-up there was no difference in the MACE rates 
(9.6% vs 11%). Conclusions: Despite the greater clinical and 
angiographic complexity, PCI using the radial access is safe 
and effective, with a high procedural success rate and low 
in-hospital and late follow-up complication rates.
 
 
 
 
 
 
DEsCrIPTOrs: Radial artery. Angioplasty. Stents. Hemorrhage. 
Aged.
1 Physician. Director of the Invasive Cardiology Sector of the Hospital 
Regional de Teixeira de Freitas. Teixeira de Freitas, BA, Brazil.
2 Physician at the Endovascular Surgery and Interventional Radiology 
Sector of the Hospital Regional de Teixeira de Freitas. Teixeira de 
Freitas, BA, Brazil.
3 Nurse at the Haemodynamics Sector of the Hospital Regional de 
Teixeira de Freitas. Teixeira de Freitas, BA, Brazil.
4 Cardiologist physician of the Hospital Regional de Teixeira de Freitas. 
Teixeira de Freitas, BA, Brazil.
5 Cardiologist physician of the Hospital Regional de Teixeira de Freitas. 
Teixeira de Freitas, BA, Brazil.
6 Cardiologist physician of the Hospital Regional de Teixeira de Freitas. 
Teixeira de Freitas, BA, Brazil.
7 Cardiologist physician of the Hospital Regional de Teixeira de Freitas. 
Teixeira de Freitas, BA, Brazil.
Correspondence to: Clarissa Campo Dall’Orto. Avenida Presidente 
Getulio Vargas, 4.579 – Teixeira de Freitas, BA, Brazil – CEP 45998-400
E-mail: clarissadallorto@ig.com.br
Received on: 1/8/2013 • Accepted on: 3/5/2013
Original Article
rEsUMO
Intervenção Coronária Percutânea por Acesso 
Transradial em Pacientes Idosos vs. Não-Idosos
Introdução: A via radial é objeto de interesse crescente de 
cardiologistas intervencionistas, por oferecer diversas vanta-
gens, entre elas a redução da taxa de sangramento e eventos 
cardíacos adversos maiores (ECAM). Entretanto, apesar de os 
idosos apresentarem maior risco de sangramento da via de 
acesso, a utilização da via radial é motivo de controvérsias, 
pela maior complexidade anatômica desses pacientes. Méto-
dos: Estudo retrospectivo, que incluiu pacientes submetidos a 
intervenção coronária percutânea (ICP) por via radial, divididos 
nos grupos idoso (≥ 65 anos) e não-idoso (< 65 anos). Foram 
analisados os perfis clínico, angiográfico e do procedimento, 
além da evolução tanto inicial como tardia. resultados: No 
grupo idoso foram incluídos 131 pacientes (145 ICPs) e no 
grupo não-idoso, 149 pacientes (176 ICPs). O grupo idoso 
apresentou mais frequentemente menor índice de massa cor-
poral e de tabagistas, e maiores taxas de insuficiência renal 
crônica, doença arterial periférica, quadros clínicos estáveis, 
doença multiarterial e lesões calcificadas. Não houve dife-
rença nas taxas de troca de via de acesso (4,8% vs. 3,4%), 
tempo de fluoroscopia (15,3 ± 10,3 minutos vs. 16,1 ± 10,3 
minutos), tempo do procedimento (40,6 ± 26,4 minutos vs. 
46,4 ± 53,6 minutos), sucesso tanto angiográfico (96,3% vs. 
97,5%) como clínico (94,5% vs. 95,4%), ECAM (3,4% vs. 
3,4%) e sangramentos (0,21% vs. 0,6%) na fase hospitalar. 
No seguimento tardio também não houve diferença nas taxas 
de ECAM (9,6% vs. 11%). Conclusões: Apesar da maior com-
plexidade tanto clínica como angiográfica, a realização de ICP 
por via radial em idosos é segura e eficaz, com elevado índice 
de sucesso do procedimento e baixa taxa de complicações 
hospitalares e tardias.
DEsCrITOrEs: Artéria radial. Angioplastia. Stents. Hemor-
ragia. Idoso.
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Infarction study7 (TIMI; minimum: any clinical sign 
of bleeding associated with decrease in hemoglo-
bin < 3 g/dL; minor: any clinical signs of bleeding 
associated with a decrease in hemoglobin of 3 g/dL 
to 5 g/dL; and major: intracranial hemorrhage, sign 
of clinically significant bleeding associated with de-
crease in hemoglobin > 5 g/dL, or fatal bleeding) and 
according to the criteria of the Bleeding Academic 
Research Consortium8 (BARC; type 0: no bleeding; 
type 1: minor bleeding not requiring medical atten-
tion or hospitalisation; type 2: any sign of bleeding 
that does not fit types 3, 4, or 5, but has at least 
one of the following criteria: non-surgical medical 
intervention, need for hospitalisation or increased 
level of care, requiring clinical assessment; type 3A: 
bleeding associated with a decrease in hemoglobin of 
3 g/dL to 5  g/dL or bleeding requiring blood transfu-
sion; type 3B: bleeding associated with a decrease in 
hemoglobin > 5 g/dL, cardiac tamponade, bleeding 
requiring surgical treatment for control except dental/
nasal/skin/hemorrhoids or bleeding requiring the use 
of vasoactive drugs; type 3C: intracranial bleeding, 
except micro-bleeding or hemorrhagic transforma-
tion, different subcategories of bleeding confirmed 
by autopsy, imaging assessment or peritoneal lavage 
or intraocular bleeding that compromises vision; 
type 4: bleeding related to CABG; and type 5: fatal 
bleeding).
Major adverse cardiac events were defined as a 
combination of cardiac death, non-fatal acute myocardial 
infarction, or need for target-vessel revascularisation. The 
criterion of reinfarction after the procedure adopted was 
the TIMI,7 which considers that, for patients within 48 
hours of the index procedure, three conditions must be 
present: documentation that creatine kinase MB fraction 
(CK-MB) was decreased (or total creatine phosphokinase 
[CPK] if CK-MB is not available), CK-MB obtained at 
least four hours after the procedure > three times the 
upper limit of normal (or total CPK, when CK-MB is 
not available), and increase in CK-MB of at least 50% 
of the previous value.
Angiographic success was defined as percentage of 
stenosis diameter < 30% with final TIMI 3 flow. Stent 
thrombosis was classified as acute, sub-acute, late, and 
very late, according to the criteria of the Academic 
Research Consortium (ARC).9
Statistical analysis
Continuous variables were expressed as means and 
standard deviations and compared using Student’s t-test 
for independent samples. Qualitative variables were 
expressed as numbers and percentages and compared 
using the chi-squared or Fisher’s exact test, as appro-
priate. SPSS for Windows, version 12.0, was used 
for the statistical analyses, and a p-value < 0.05 was 
considered significant.
The radial access approach has been the subject of increasing interest for diagnostic and therapeutic procedures worldwide and also in Brazil, since it 
has several advantages, such more convenience for the 
patient in the immediate post-procedure, with earlier 
return to activities, decreased hospitalisation time, with 
consequent reduction in hospital costs, and a low 
complication rate at the puncture site when compared 
with the femoral approach, reducing the rate of major 
bleeding, which, in turn, is associated with increased 
risk of death and ischemic events.1-4
This access is particularly important in scenarios 
associated with high risk of bleeding, such as acute 
coronary syndromes, in which the use of antiplatelet 
and antithrombotic therapies is more aggressive, in 
female patients, and in the elderly.5,6 However, radial 
access in the elderly may be a more difficult approach 
due to tortuosity and arterial stenosis.
This study aimed to evaluate the clinical, angiog-
raphic, and procedural profiles, as well as the initial 
and late evolution of elderly patients, when compared 
to non-elderly patients submitted to percutaneous 
coronary intervention (PCI) through radial access, 
in an unselected population representative of daily 
clinical practice.
MethodS
This was a retrospective study, which included all 
consecutive patients submitted to PCI through radial 
access from June of 2011 to December of 2012, divided 
into two groups: elderly (≥ 65  years) and non-elderly 
(≤ 65 years). Patients with chronic renal failure submitted 
to dialysis with fistula in the right upper limb and those 
in cardiogenic shock were excluded.
The radial artery puncture was performed with the 
patient with the right arm extended to the side and 
hand in the supine position, under local anaesthesia 
with 2 to 3 mL of 2% lidocaine. A Jelco 20 catheter 
was used to puncture the artery; after puncture, 5F to 
7F arterial sheaths were inserted, which were specific 
for the radial artery, with 11 cm of length. After the 
procedure, the arterial sheath was removed in the operat-
ing room without heparin reversal, and a compression 
dressing was applied, which was usually removed two 
hours after the procedure.
All patients received a loading dose of 300 mg 
acetylsalicylic acid and 600 mg of clopidogrel, followed 
by a maintenance dose of 100 mg and 75 mg per day, 
respectively, as well as intravenous unfractionated hepa-
rin during the procedure, at a dose of 70 to 100 U/kg.
Patients were followed after hospital discharge, 
and follow-up occurred at one month, three months, 
six months, and one year through medical consultation 
or telephone contact. Bleeding was defined accord-
ing to the criteria of the Thrombolysis in Myocardial 
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ReSultS
From June of 2011 to December of 2012, 280 pa-
tients underwent 321 PCIs by radial access; 131 patients 
(145 PCIs) were categorized as elderly and 149 patients 
(176 PCIs) as non-elderly. The mean ages in the elderly 
and non-elderly groups were 74 ± 6.3 years and 54 ± 
6.9 years, respectively. The elderly group had lower 
body mass index, fewer smokers, higher additive and 
logistic EuroSCORE, and higher incidence of chronic 
renal failure and peripheral artery disease (Table 1).
Regarding the angiographic characteristics, the only 
differences were the extent of coronary disease, most 
often three-vessel disease (33.6% vs. 16.1%), and severe 
coronary calcification (11.6% vs. 2.5%; P < 0.01) in 
the elderly group (Table 2).
There was no difference in the rates of access-site 
crossover (4.8% vs. 3.4%; P = 0.83), contrast volume 
(103.1 ± 41.2 mL vs. 108.7 ± 42.2 mL; P = 0.23), fluor-
oscopy time (15.3 ± 10.3 min vs. 16.1 ± 10.3 minutes; 
P = 0.45), procedure time (40.6 ± 26 4 minutes vs. 
46.4 ± 53.6 minutes; P = 0.23), and angiographic suc-
cess (96.3% vs. 97.5%; P = 0.99) (Table 3). All stents 
used were bare-metal stents. Variables obtained in the 
quantitative coronary angiography are shown in Table 4.
When analysing the in-hospital outcome (Table 5), 
there was one case of acute stent thrombosis in the 
elderly group (0.7%) and one case of sub-acute throm-
bosis in the non-elderly group (0.6%), with myocardial 
infarction without ST-segment elevation (NSTEMI) and 
consequent urgent percutaneous reintervention in each 
group. There was one case of emergency surgery in 
Table 1  
Clinical characteristics
Elderly group
(n = 131 patients)
Non-elderly group
(n = 149 patients) P-value
Age in years, mean ± SD 74 ± 6.3 54 ± 6.9 < 0.01
Female gender, n (%) 52 (39.7) 53 (35.6) 0.72
Body mass index, n (%) 25.4 ± 3.9 27 ± 4.2 < 0.01
Additive EuroSCORE, mean ± SD 6.6 ± 2.9 2.9 ± 2.3 < 0.01
Logistic EuroSCORE, mean ± SD 9 ± 9.6 2.8 ± 3 < 0.01
SAH, n (%) 124 (94.7) 127 (85.2) 0.61
Dyslipidaemia, n (%) 65 (49.6) 69 (46.3) 0.82
Family history of CAD, n (%) 11 (8.4) 31 (20.8) 0.02
Smoking, n (%) 11 (8.4) 40 (26.8) < 0.01
Diabetes mellitus, n (%) 37 (28.2) 33 (22.1) 0.44
Previous AMI, n (%) 39 (29.8) 34 (22.8) 0.38
Previous PCI, n (%) 7 (5.3) 7 (4.7) 0.97
Previous CABG, n (%) 7 (5.3) 6 (4) 0.83
Chronic renal failure, n (%) 91 (69.5) 28 (18.8) < 0.01
Previous stroke, n (%) 4 (3.1) 3 (2) 0.87
POAD, n (%) 44 (33.6) 5 (3.4) < 0.01
Clinical picture, n (%) 0.04
Anginal equivalent 2 (1.5) 2 (1.3)
Silent ischemia 4 (3.1) 2 (1.3)
Stable angina 51 (38.9) 50 (33.6)
Unstable angina 26 (19.8) 17 (11.4)
NSTEMI 16 (12.2) 15 (10.1)
STEMI, acute phase 24 (18.4) 48 (32.2)
STEMI, with streptokinase (> 24 h) 0 5 (3.4)
STEMI, clinical treatment (> 24 h) 8 (6.1) 10 (6.7)
SAH, systemic arterial hypertension; CAD, coronary artery disease; AMI, acute myocardial infarction; PCI, percutaneous coronary 
intervention; CABG, coronary artery bypass grafting; POAD, peripheral obstructive artery disease; NSTEMI, non-ST segment elevation 
myocardial infarction; STEMI, ST-segment elevation myocardial infarction.
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coronary artery with angiographic success, the patient 
had ventricular septal rupture and, despite the surgery, 
eventually died. Regarding other deaths, there were 
three deaths in the elderly group: one cardiac death, 
one due to septic shock from pneumonia associated 
the non-elderly group, corresponding to a patient 
with acute myocardial infarction with ST-segment 
elevation (STEMI) in the inferior wall, with a ten-hour 
interval between symptom onset and the seeking of 
care. Although primary PCI was performed in the right 
Table 2 
Angiographic characteristics
Elderly group
(n = 131 patients/ 190 lesions)
Non-elderly group
(n = 149 patients/ 236 lesions) P-value
SYNTAXa score, n (%) 0.40
0-22 94 (71.8) 119 (79.9)
23-32 22 (16.8) 17 (11.4)
> 33 7 (5.3) 4 (2.7)
Extent of coronary disease, n (%) 0.03
One-vessel 48 (36.6) 66 (44.3)
Two-vessel 39 (29.8) 59 (39.6)
Three-vessel 44 (33.6) 24 (16.1)
Intrastent restenosis treatment, n (%) 3 (1.6) 13 (5.5) 0.07
AHA classification, n (%) 0.30
A 11 (5.8) 14 (5.9)
B1 35 (18.4) 57 (24.1)
B2 79 (41.6) 78 (33.1)
C 65 (34.2) 87 (36.9)
SCAI classification 0.21
I 96 (50.5) 132 (55.9)
II 49 (25.8) 59 (25.1)
III 17 (8.9) 22 (9.3) IV
IV 28 (14.8) 23 (9.7)
Significant calcification, n (%) 22 (11.6) 6 (2.5) < 0.01
Bifurcation, n (%) 24 (12.6) 27 (11.4) 0.85
a The SYNTAX score was not calculated for patients with surgical revascularisation.
SYNTAX, [SALTO]; AHA, American Heart Association; SCAI, Society for Cardiac Angiography and Interventions.
Table 3 
Procedural characteristics
Elderly group
(n = 145 procedures/190 lesions)
Non-elderly group
(n = 176 procedures/236 lesions) P-value
Access-site crossover, n (%) 7 (4.8) 6 (3.4) 0.83
Volume contrast, mL 103.1 ± 41.2 108.7 ± 42.2 0.23
Fluoroscopy time, min 15.3 ± 10.3 16.1 ± 103 0.45
Procedure time, min 40.6 ± 26.4 46.4 ± 53.6 0.23
Predilation, n (%) 84 (44.2) 120 (50.8) 0.47
Balloon/artery ratio 1.12 ± 0.34 1.09 ± 0.28 0.75
Stent/lesion proportion, mm 1 ± 0.2 1.1 ± 0.3 0.22
Maximum pressure, atm 13.1 ± 1.97 134.4 ± 2.07 0.87
Angiographic success, n (%) 183 (96.3) 230 (97.5) 0.99
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Table 4  
Quantitative coronary angiography
Elderly group
(n = 190 lesions)
Non-elderly group
(n = 236 lesions) P-value
Pre-PCI
Maximum diameter, mm 3 ± 0.8 2.9 ± 0.69 0.17
Length, mm 16.2 ± 7.55 15.8 ± 7.37 0.58
Reference diameter, mm 2.6 ± 0.53 2.6 ± 1.2 > 0.99
Minimum luminal diameter, mm 0.7 ± 0.34 0.7 ± 0.29 > 0.99
Stenosis diameter, mm 77.1 ± 13.5 78.9 ± 14.9 0.20
Post-PCI
Maximum diameter, mm 3.1 ± 0.49 3.1 ± 0.42 > 0.99
Length, mm 16.5 ± 7.61 17.3 ± 9.69 0.35
Reference diameter, mm 2.8 ± 0.5 2.9 ± 0.43 0.27
Minimum luminal diameter, mm 2.5 ± 0.46 2.5 ± 0.45 > 0.99
Stenosis diameter, mm 13.3 ± 11 12.6 ± 11.9 0.53
Acute gain, mm 1.89 ± 0.48 1.98 ± 0.57 0.08
PCI, percutaneous coronary intervention.
Table 5  
In-hospital clinical events
Elderly group
(n = 145 procedures)
Non-elderly group
(n = 176 procedures) P-value
Time of hospitalisation, days 3.1 ± 5.1 2.5 ± 3.2 0.2
MACE, n (%) 5 (3.4) 6 (3.4) 0.77
Death, n (%) 3 (2.1) 2 (1.2) 0.84
Cardiac 1 (0.7) 2 (1.2)
Non-cardiac 2 (1.4) 0
AMI, n (%) 1 (0.7) 1 (0.6) 0.57
Urgent PCI, n (%) 1 (0.7) 1 (0.6) 0.57
Urgent surgery, n (%) 0 1 (0.6) 0.92
Acute stent thrombosis, n (%) 1 (0.7) 0 0.93
Sub-acute stent thrombosis, n (%) 0 1 (0.6) 0.92
Contrast-induced nephrotoxicity, n (%) 9 (6.2) 10 (5.7) 0.96
Bleeding according to TIMI criteria, n (%) 0.51
Minimum 1 (0.7) 1 (0.6)
Minor 1 (0.7) 0
Major 1 (0.7) 0
Bleeding according to BARC criteria, n (%) 0.51
Type 1 1 (0.7) 1 (0.6)
Type 2 1 (0.7) 0
Type 3B 1 (0.7) 0
Type 3A, 3C, 4 and 5 0 0
Clinical success, n (%) 137 (94.5) 168 (95.4) 0.76
MACE, major adverse cardiac events; AMI, acute myocardial infarction; PCI, percutaneous coronary intervention; TIMI, Thrombolysis in 
Myocardial Infarction; BARC, Bleeding Academic Research Consortium.
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Table 6  
Late clinical events
Elderly group
(n = 114 patients)
Non-elderly group
(n = 136 patients) P-value
Number of patients per follow-up period, n (%)
One month 108 (94.7) 127 (93.4) 0.75
Three months 92 (80.7) 115 (84.6) 0.83
Six months 65 (57) 95 (69.9) 0.35
One year 38 (33.4) 59 (43.4) 0.31
Time of follow-up, days 139.9 ± 146.7 151.3 ± 149.5 0.55
Staged treatment, n (%) 15 (13.1) 22 (16.2) 0.67
Clinical intrastent restenosis, n (%) 6 (5.2) 14 (10.3) 0.25
Major adverse cardiac events, n (%) 11 (9.6) 15 (11) 0.67
Death, n (%) 7 (6.1) 6 (4.4) 0.78
Acute myocardial infarction, n (%) 0 1 (0.7) 0.93
Target-lesion revascularisation, n (%) 2 (1.7) 5 (3.7) 0.60
Target-vessel revascularisation, n (%) 4 (3.5) 9 (6.6) 0.43
PCI, n (%) 12 (10.5) 25 (18.4) 0.17
CABG, n (%) 6 (5.2) 7 (5.1) 0.79
PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting.
with mechanical ventilation, and another from sepsis in 
a patient with peripheral artery disease (diabetic foot), 
all in the post-STEMI phase. In the non-elderly group, 
there was another death, in addition to the previously 
reported, from cardiogenic shock in the evolution phase 
of STEMI. There was only one case of severe bleeding 
in the elderly group (major and type 3B by TIMI and 
BARC criteria, respectively), which occurred in one 
of the patients who had access-site crossover to the 
femoral artery, requiring vascular surgery.
At the late follow-up (139.9 ± 146.7 days vs. 151.3 
± 149.5 days; P = 0.55), there was no difference in the 
rate of major adverse cardiac events (9.6% vs. 11%; 
P = 0.67), death (6.1% vs. 4.4%; P = 0.78), myocardial 
infarction (0 vs. 0.7%; P = 0.93), target-vessel revascu-
larization (3.5% vs. 6.6%; P = 0.43), or target-lesion 
revascularization (1.7% vs. 3.7%; P = 0.60) (Table 6). 
There were no late or very late stent thromboses in 
this period.
diScuSSion
In the authors’ experience, PCI through radial access 
has shown to be as effective in elderly patients as in 
younger patients, with high technical success rate, low 
rate of crossover, and very good safety, as puncture 
site bleeding and complications very rarely occurred 
in the assessed sample. Transradial PCI can be safely 
performed in elderly patients. 
In the present sample, chronic renal failure was 
more common in the elderly, as was multivessel disease. 
The fluoroscopy and procedure time, as well as rates of 
vascular complications, cardiac death, and procedural 
success did not differ between groups in the present 
study. These results are consistent with those reported 
by Cao et al.10
In the study by Andrade et al.,11 despite the mean 
age of 70 years and the prevalence of procedures in the 
presence of acute coronary syndrome, including 22% 
primary PCI, a high success rate and low prevalence 
of angiographic complications were attained, requiring 
access-site crossover in less than 3% of cases, with no 
need for excess time for its performance or increased 
use of materials.
Studies have demonstrated that PCI through femo-
ral access in elderly patients has a higher incidence 
of vascular complications when compared to younger 
patients.12-14 In the “Prevention of Ischemic Complications 
(EPIC)” study,15 older age was an independent risk factor 
for vascular complications and bleeding related to the 
puncture site after femoral approach. Although the use 
of arterial closure devices may reduce the incidence of 
problems after the femoral approach, elderly patients 
still have a higher rate of vascular complications.16,17
Although older patients have more radial artery 
tortuosity in the brachiocephalic trunk and subclavian 
artery, this had no impact on the procedural success 
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rate. These findings suggest that technical failure due 
to anatomical characteristics is rare and non-significant 
in transradial procedures in the elderly.
Study limitations
The present study has the inherent limitations of 
retrospective and observational studies. An important 
limitation is its performance in a single center with 
a relatively small number of patients, in whom the 
radial access is predominant for both diagnostic and 
therapeutic coronary procedures.
concluSionS
Despite the greater clinical and angiographic 
complexity, PCI through the radial access is safe and 
effective, with a high procedural success rate and low 
in-hospital and late follow-up complication rates.
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